CD34 Expression in Adult Acute Lymphoblastic Leukemia

References

• Huang S., Terstappen L. W. M. M. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38-hematopoietic stem cells. Blond 1994; 83: 1515–1526
   PubMed Web of Science ®Google Scholar
• Majdic O., Stockl J., Pickl W. F., Bohuslav J., Strobl H., Scheinecker C., Stockinger H., Knapp W. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 1994; 83: 1226–1234
   PubMed Web of Science ®Google Scholar
• Civin C. I., Banquerigo M. L., Strauss L. C., Loken M. R. Antigenic analysis of hematopoiesis, IV. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol. 1987; 15: 10–16
   PubMed Web of Science ®Google Scholar
• Geller R. B., Zahurak M., Hurwitz C. A., Burke P. J., Karp J. E., Piantadosi S., Civin C. I. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My 10). Br. J. Haematol. 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Consoli U., Guylielmo PC., Acciola E., Jr., Zingali A., Caloyero R. D., Mana G., Giustolisi R., Cacciola E. The stem cell antigen CD34 in adult acute lymphoblastic leukemia. Proceedings of the 24th ISH Congress. London August, 1992; 23–27; 1465, abstract
   Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. C., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukemias: French-American-British (FAB) Co-operative Group. Br. J. Haematol. 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• GIMEMA Cooperative Group., Update of the GIMEMA ALL/0288 study for adult acute lymphoblastic leukemia. Proceedings of the 24th ISH Congress. London August, 1992; 61: 23–27, abstract
   Google Scholar
• Keating M. J., Smith T. C., Gehan E. A., McCredie K. B., Bodey G. P., Spitzer G., Hersh E., Gutterman J., Freireich E. J. Factors related to lenght of complete remission in adult leukaemia. Cancer 1980; 45: 2017–2029
   PubMed Web of Science ®Google Scholar
• Cacciola E., Guglielmo PC., Acciola E., Jr., Stagno F., Impera S., Ferrigno G., Giustolisi R. Biological role of pluripotent stem cell antigen CD34 in leukemic hematopoiesis. Molecular Biology of Hematopoiesis, N. G. Abraham, R. K. Shadduck, A. S. Levine, F. Takaku. Intercept, Andover 1993; Vol. III: 329–336
   Google Scholar
• Ross C. W., Stoolman L. M., Schnitzer B., Schlegelmilch J. A., Hanson C. A. Immunophenotypic aberrancy in adult lymphoblastic leukemia. Am. J. Clin. Pathol. 1990; 94: 590–599
   PubMed Web of Science ®Google Scholar
• Watt S. M., Williamson J., Genevier H., Fawcett J., Simmons D. L., Hatzfeld A., Nesbitt S. A., Coombe D. R. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 1993; 82: 2649–2663
   PubMed Web of Science ®Google Scholar
• Bradstock K., Makrynikola V., Bianchi A., Byth K. Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts. Blood 1993; 82: 3437–3444
   PubMed Web of Science ®Google Scholar
• Makrynikola V., Bradstock K. Adhesion of precursor-B-acute lymphoblastic leukemia cells to bone marrow stromal proteins. Leukemia. 1993; 7: 86–92
   PubMed Web of Science ®Google Scholar
• Eder M., Ottman Hansen-G. O., Hagge T. E., Bartram C. R., Falk S., Gillis S., Hoelzer D., Ganser A. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. Blood 1992; 79: 3274–3284
   PubMed Web of Science ®Google Scholar
• Manabe A., Coustan-Smith E., Campana D. Bone-marrow derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood. 1992; 79: 2370–2377
   PubMed Web of Science ®Google Scholar
• Teixido J., Hemler M. E., Greenberger J. S., Anklesaria P. Role of β1 and β2 integrins in the adhesion of human CD34 HI stem cells to bone marrow stroma. J. Clin. Invest. 1992; 90: 358–367
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• Boekhorst P. A. W., Leew K., Schoester M., Wittebol S., Nooter K., Hagemeijer A., Lowenberg B., Sonneveld P. Predominance of functional multidrug resistance (MDR-I) pheno-type in CD34+ acute myeloid leukemia cells. Blood 1993; 82: 3157–3162
   PubMed Web of Science ®Google Scholar
• Miwa H., Kita K., Nishii K., Morita N., Takakura N., Ohishi K., Mahmud N., Kageyama S., Fukumotu M., Shirekawa S. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood 1993; 82: 3445–3451
   PubMed Web of Science ®Google Scholar
• Ludescher C., Hilbe W., Eisterer W., Thaler J. Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay. Blood 1993; 82: 3505–3506
   PubMed Web of Science ®Google Scholar
• Fenneteau O., Marie J. P., Lescoeur B., Vilmer E., Schlegel N. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia. Blood 1993; 82: 3787–3788
   PubMed Web of Science ®Google Scholar
• Nooter K., Herweijer H. Multidrug resistance (mdr) genes in human cancer. Br. J. Cancer 1991; 63: 663–669
   PubMed Web of Science ®Google Scholar
• Arceci R. J. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 1993; 81: 2215–2222
   PubMed Web of Science ®Google Scholar